Phase 3 CONDOR Study of PYL: The Potential To Improve The Outcome of Recurrent Prostate Cancer

490 words 8% vs 1306 words 3% According to a recent Globe Newswire release, Progenics Pharmaceuticals, an oncology company that specializes in artificial intelligence and targeted therapies, announced results for its Phase…

Continue Reading Phase 3 CONDOR Study of PYL: The Potential To Improve The Outcome of Recurrent Prostate Cancer
Despite a Newly Approved Treatment, The Cystic Fibrosis Foundation Isn’t Slowing Down its Efforts
Free-Photos / Pixabay

Despite a Newly Approved Treatment, The Cystic Fibrosis Foundation Isn’t Slowing Down its Efforts

According to a story from statnews.com, the approval of the new cystic fibrosis drug Trikafta has caused quite a buzz in this rare disease community. While this new drug offers…

Continue Reading Despite a Newly Approved Treatment, The Cystic Fibrosis Foundation Isn’t Slowing Down its Efforts

CMS is so Rare That it Took Four Years to Enroll Twenty People for a Trial

  According to a recent article in Biospace, Catalyst Pharmaceutical’s CMS-001 Phase 3 study ended with mixed results. The trial was billed as the first placebo-controlled double-blind study testing amifampridine phosphate (brand…

Continue Reading CMS is so Rare That it Took Four Years to Enroll Twenty People for a Trial
A Team of Scientists are Working on a Researching Treatments for Ulcerative Colitis
luvqs / Pixabay

A Team of Scientists are Working on a Researching Treatments for Ulcerative Colitis

According to a story from Medical Xpress, an international team of scientist from 34 different countries are putting their heads together to identify the most effective treatments for ulcerative colitis,…

Continue Reading A Team of Scientists are Working on a Researching Treatments for Ulcerative Colitis
Doctors Call for Screening of Juvenile Idiopathic Arthritis Patients to Identify Rare Lung Disease
nastya_gepp / Pixabay

Doctors Call for Screening of Juvenile Idiopathic Arthritis Patients to Identify Rare Lung Disease

According to a story from newswise.com, biologic medicines have had a major positive impact on outcomes for patients with the rare disease juvenile idiopathic arthritis (JIA). However, as these medicines…

Continue Reading Doctors Call for Screening of Juvenile Idiopathic Arthritis Patients to Identify Rare Lung Disease